Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury.

MLA

Ming-Gui Wang, et al. “Plasma Metabolomic and Lipidomic Alterations Associated with Anti-Tuberculosis Drug-Induced Liver Injury.” Frontiers in Pharmacology, vol. 13, Oct. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fphar.2022.1044808.

APA

Ming-Gui Wang, Shou-Quan Wu, Meng-Meng Zhang, & Jian-Qing He. (2022). Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury. Frontiers in Pharmacology, 13, 1–12. https://doi.org/10.3389/fphar.2022.1044808

Chicago

Ming-Gui Wang, Shou-Quan Wu, Meng-Meng Zhang, and Jian-Qing He. 2022. “Plasma Metabolomic and Lipidomic Alterations Associated with Anti-Tuberculosis Drug-Induced Liver Injury.” Frontiers in Pharmacology 13 (October): 1–12. doi:10.3389/fphar.2022.1044808.